Sun Pharmaceutical Industries Limited has informed the Exchange about Schedule of meet
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sun Pharmaceutical has informed the exchanges about the schedule for announcing its Q4 FY2026 financial results for the quarter ending 31 March 2026. The company will release its earnings on 22 May 2026 and host an earnings conference call at 06:30 pm IST the same day. The call will last approximately one hour, during which senior management will discuss performance and answer participant questions. Investors can pre-register for the call using the provided telephone numbers or participate via audio webcast on the company website. This is a routine scheduled announcement with no actual financial figures disclosed.
Neutral for shareholders — this is a standard schedule notification ahead of Q4 earnings release. Actual impact on the stock will depend on the financial results announced on 22 May 2026.